; (2) the nature of the clinical assessment that was associated with such tests, items, and services; (3) whether such individual was showing symptoms prior to being furnished such tests, items, and services; (4) in the case of such tests, whether or not such tests were ordered by a provider; (5) the frequency with which such individual is furnished such tests, items, and services; and (6) any other review of the encounters or events that preceded or followed the furnishing of such tests, items, and services. . 308. Guidance on billing for provider visits associated with COVID–19 testing The Secretary of Health and Human Services, the Secretary of Labor, and the Secretary of the Treasury shall jointly issue guidance not later than 30 days after the date of enactment of this Act for purposes of clarifying— (1) the process for submitting claims for tests, items, and services described in section 6001(a) of the Families First Coronavirus Response Act ( Public Law 116–127 ) to ensure that individuals enrolled in individual or group health insurance coverage or group health plans (including grandfathered health plans (as defined in section 1251(e) of the Patient Protection and Affordable Care Act)) to whom such tests, items, and services are furnished are not subject to cost-sharing (including deductibles, copayments, and coinsurance) or prior authorization or other medical management requirements; and (2) that providers should not collect cost-sharing amounts from such individuals seeking such tests, items, or services. 309. Improvements to transparency of the pricing of diagnostic testing for COVID–19 (a) In general Section 3202 of the CARES Act ( Public Law 116–136 ) is amended— (1) in subsection (b)— (A) in the heading, by inserting and related items and services after diagnostic testing for COVID–19 ; (B) in paragraph (1)— (i) by striking a diagnostic test for COVID–19 and inserting a test, item, or service described in section 6001(a) of division F of the Families First Coronavirus Response Act